Skip to content

Evaluation of the effect of gabapentin on patients restlessness after rhinoplasty

Evaluation of the effect of gabapentin on patients restlessness after rhinoplasty

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200907048652N2
Enrollment
120
Registered
2021-01-02
Start date
2019-09-04
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinoplasty surgery.

Interventions

Intervention 1: Intervention group: Patients were given two 300 mg (600 mg) capsules of gabapentin half an hour before surgery, with a small amount of water. Intervention 2: Control group: In the cont

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
17 Years to 55 Years

Inclusion criteria

Inclusion criteria: All female candidates for rhinoplasty with ASA class I or II that were referred to Amir Al-Momenin Hospital, Namazi or Kosar Hospital in Shiraz.

Exclusion criteria

Exclusion criteria: Patients with a diagnosis of dementia, patients with severe preoperative anxiety (yes or no is asked by the physician), patients with impaired kidney function, patients with a long history (more than 1 month) of anti-anxiety drugs, antidepressants, Neuroleptics, benzodiazepines, diabetics and patients with a history of chronic pain were not included in the study.

Design outcomes

Primary

MeasureTime frame
Post operative restlessness. Timepoint: Immediately after the operation and then at the time of recovery. Method of measurement: Based on Riker sedation - agitated scale to measure arterial oxygen saturation, arterial blood pressure, heart rate and exhaled CO2.;Pain level. Timepoint: at the time of recovery. Method of measurement: Based on the Numeric Rating Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamidreza Hosseinpour

Shiraz University of Medical Sciences

hp_hamid@ymail.com+98 71 3631 1594

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026